SUBSCRIBE
SUBSCRIBE

Postmarket research

Drug Development
Cancer-Seeking Antibodies Guide Light-Sensitive Drugs
September 5, 2007
 · 
1 min read
Drug Development
Forget What Your Drug Was Approved For
August 31, 2007
 · 
1 min read
Drug Development
Human Papilloma Virus Vaccines May Decrease Chances of Oral Cancer
August 31, 2007
 · 
1 min read
Drug Development
AIDS Drug Shows Potential as Weapon Against Cancer
August 31, 2007
 · 
1 min read
Drug Development
Bupropion Doesn’t Prevent Smoking in ADHD Patients
August 30, 2007
 · 
1 min read
Drug Development
Scientists Puzzled by Severe Allergic Reaction to Cancer Drug in the Middle Southern U.S.
August 29, 2007
 · 
1 min read
Drug Development
No New Brain Infection Cases with MS Drug Biogen Idec, Inc. (Massachusetts)'s Tysabri
August 28, 2007
 · 
1 min read
Drug Development
A Heart Drug May Hold Off Alzheimer’s
August 28, 2007
 · 
1 min read
Drug Development
Oral Sex Implicated in Some Throat and Neck Cancers; Suggests Boys Need Merck & Co., Inc. (Jobs) Vaccine
August 28, 2007
 · 
1 min read
Drug Development
Humana, Inc., University of Miami to Research Drug Effects
August 24, 2007
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Azathioprine Adds Nothing in IgA Nephropathy, Researchers Report in the Journal of the American Society of Nephrology
July 19, 2010
 · 
1 min read
Drug Development
Pfizer Inc.'s Coxib Triggers Fewer Lower GI Events Than NSAID + PPI
July 19, 2010
 · 
1 min read
Drug Development
Abbott Laboratories’s PROGRESS Study of Kaletra and Isentress Compared with a Standard HIV Regimen Meets the Pre-Specified Primary Efficacy Endpoint
July 19, 2010
 · 
12 min read
Drug Development
Roche’s New Avastin Studies Not as Good as Early Data, FDA Says
July 16, 2010
 · 
1 min read
Drug Development
Roche’s MMF Effective for Membranous Lupus Nephritis; Comparable to Tacrolimus
July 15, 2010
 · 
1 min read
Drug Development
Biogen Idec, Inc. (Massachusetts) And Genentech’s Rituximab Shows Promise for Severe ANCA-Associated Vasculitis
July 15, 2010
 · 
1 min read
Drug Development
Clinuvel Release: Successful Drug Trial Results for Light Intolerant ‘Shadow Jumpers’
July 13, 2010
 · 
1 min read
Drug Development
Graceway Pharmaceuticals, LLC Release: New Data Demonstrate Zyclara(TM) Imiquimod 3.75% Superior to Placebo for Treatment of External Genital Warts (EGW)
July 9, 2010
 · 
1 min read
Drug Development
UCB, Inc.: New Data for Vimpat(R) (Lacosamide) C-V Showed Sustained Efficacy for Up to 5 Years and Improved Seizure Control When Added to a Broad Range of Antiepileptic Drugs
June 29, 2010
 · 
11 min read
Drug Development
Eli Lilly and Company’s Effient Tied in Study to Higher Rate of Cancer Risk Than Plavix
June 29, 2010
 · 
1 min read
Drug Development
Bristol-Myers Squibb Company Release: ONGLYZA(TM) (saxagliptin) With Metformin as Initial Combination Therapy Provided 76-Week Long-Term Glycemic Control in Treatment-Naïve Adults With Type 2 Diabetes
June 28, 2010
 · 
1 min read
Drug Development
Daiichi Sankyo, Inc. New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes
June 28, 2010
 · 
9 min read
Drug Development
ONGLYZA(TM) (saxagliptin) With Metformin as Initial Combination Therapy Provided 76-Week Long-Term Glycemic Control in Treatment-Naïve Adults With Type 2 Diabetes
June 28, 2010
 · 
1 min read
Drug Development
Bristol-Myers Squibb Company Release: 52-Week Study Finds ONGLYZA(TM) (saxagliptin) When Added to Metformin Was Non-Inferior to Titrated Glipizide When Added to Metformin in Reducing Glycosylated Hemoglobin (HbA1c)
June 28, 2010
 · 
1 min read
Drug Development
In a New Study, Treatment With JANUMET(R) (sitagliptin/metformin), Merck & Co., Inc.'s Diabetes Medicine, Resulted In Significantly Greater Blood Sugar Lowering Compared with Pioglitazone
June 28, 2010
 · 
1 min read
Drug Development
In a Post-Hoc Analysis, JANUVIA(R) (sitagliptin), Merck & Co., Inc.’s Diabetes Medicine, Compared with a Sulfonylurea (Glipizide) on Composite Endpoint of Lower Blood Sugar, No Hypoglycemia and No Weight Gain
June 28, 2010
 · 
1 min read
Drug Development
Depomed, Inc. New Clinical Study Shows Patients With Type 2 Diabetes May Be Able to Tolerate Higher Doses of Metformin Using GLUMETZA
June 28, 2010
 · 
8 min read
Drug Development
Sanofi-Aventis (France) Less Glycemic Variability, Better Patient Reported Outcomes with Lantus(R) and Apidra(R) Regimen vs. Premix Analog Insulin
June 28, 2010
 · 
7 min read
Drug Development
Arena Pharmaceuticals, Inc.’ Lorcaserin Reduces Body Weight and Improves Cardiovascular Risk Factors Across Patient Subgroups
June 28, 2010
 · 
6 min read
Drug Development
Amylin Pharmaceuticals, Inc.: Meta-Analysis of SYMLIN(R) Clinical Data Showed No Increased Risk of Cardiovascular Adverse Events Associated With SYMLIN Treatment in Patients With Type 2 Diabetes
June 28, 2010
 · 
8 min read
Load More